APPLIED PROCESS COMPANY LIMITED

Applied Process Company Limited (APC) is a worldwide leader in medicine development, driving the next wave of therapeutic innovation. Guided by its CEO and operator, the company is set to transform the sector by 2025 through a €100 million campus expansion that will house cutting-edge laboratories and deep-tech research facilities. Central to APC's offering is iAchieve®, an AI-driven platform that accelerates the design, optimisation and validation of new drug candidates, underpinning a robust medicine pipeline that spans discovery to early-stage development.

APC's services combine advanced laboratory capabilities with proprietary digital tools, enabling pharmaceutical partners to shorten development timelines and enhance success rates. By integrating deep-tech innovation with a collaborative, science-focused culture, the company delivers end-to-end solutions that support the creation of safer, more effective medicines for patients worldwide.